BrightSpring Health Services, Inc. (BTSG)

The company now

BrightSpring Health Services reported second-quarter 2026 revenue of $3,873 million on 31 July, up 23.0 percent from $3,148 million a year earlier 3.

Net income was $87 million, against $9 million a year earlier 3. Adjusted EBITDA, a profit measure that adds back items the company treats as one-offs, was $206 million, up 44.2 percent 3.

Pharmacy Solutions revenue rose 22 percent to $3,407 million, and Provider Services revenue rose 30 percent to $466 million 3. The pharmacy gain came from a higher revenue per prescription, $314.20 against $257.11, while prescriptions dispensed were flat at about 10.8 million 3.

Results now leave out the Community Living business, whose divestiture the company completed on 30 March 2026 3. The company raised its full-year 2026 guidance and now expects revenue of $15,100 million to $15,425 million 3.

The open question is the Amedisys and LHC branches purchase: the company expects the last three branches to close in 2026, subject to regulatory approvals 2.

As of Oct 28, 2026. Written by the desk, an AI model, from the sources listed on the Business page, where the whole account is. Nothing here is advice.

Newer filings are on file since this was written; an update is queued.